Skip to main content

Advertisement

SpringerLink
Log in

Effects of low-molecular-weight polyguluronate sulfate on experimental urolithiasis in rats

  • Original Paper
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

Urinary macromolecules, especially glycosaminoglycans (GAGs), have attracted great interest as promising inhibitors of urinary stone formation. As an analogue of GAGs, low-molecular-weight polyguluronate sulfate (LPGS) with strong polyanionic nature was prepared by chemical modification of brown algae extract. The effects of LPGS both on ethylene glycol-induced nephrolithiasis and Zinc disc implant-induced urinary bladder stone formation in Wistar rats were evaluated, and its acute toxicity in Kunming mice and Wistar rats were also investigated. The contents of renal oxalate and calcium in ethylene glycol-induced nephrolithiasic rats were decreased significantly from 5.01 ± 0.96 to 3.26 ± 1.31 μmol/g kidney (P < 0.01) and 20.11 ± 4.60 to 11.83 ± 3.54 μmol/g kidney (P < 0.01), respectively, after oral administration of LPGS at dose-level of 100 mg/kg. The renal crystal depositions and histopathological changes were reduced also. The formation of zinc disc implant-induced urinary bladder stones in rats was inhibited considerably after oral administration of LPGS at dose-levels of 50 mg/kg (P < 0.05) and 100 mg/kg (P < 0.01). The intravenous LD50 and the oral maximum tolerance value of LPGS in mice are 6.29 and 25 g/kg, and in rats are 2.25 and 10 g/kg, respectively. These data show that LPGS has significant prevention effects both on nephrolithiasis and urinary bladder stone formation in rats, and negligible oral toxicity both in mice and rats. LPGS is a safe and promising drug candidate for the prevention of urolithiasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Araujo Viel T, Diogo Domingos C, da Silva Monteiro AP, et al (1999) Evaluation of the antiurolithiatic activity of the extract of Costus spiralis Roscoe in rats. J Ethnopharmacol 66(2):193–198

    Article  PubMed  CAS  Google Scholar 

  2. Ombra MN, Casula S, Biino G, et al (2003) Urinary glycosaminoglycans as risk factors for uric acid nephrolithiasis: case control study in a Sardinian genetic isolate. Urology 62(3):416–420

    Article  PubMed  Google Scholar 

  3. Borghi L, Meschi T, Guerra A, et al (1995) Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls. Clin Chim Acta 239(1):1–11

    Article  PubMed  CAS  Google Scholar 

  4. Cao LC, Boeve ER, de Bruijn WC, et al (1997) Glycosaminoglycans and semisynthetic sulfated polysaccharides: an overview of their potential application in treatment of patients with urolithiasis. Urology 50(2):173–183

    Article  PubMed  CAS  Google Scholar 

  5. Jones M, Monga M (2003) Is there a role for pentosan polysulfate in the prevention of calcium oxalate stones? J Endourol 17(10):855–858

    Article  PubMed  Google Scholar 

  6. Tostes V, Martinusso CA, Werneck CC, et al (2004) Low-molecular-weight dextran sulfate prevents experimental urolithiasis in rats. Clin Chim Acta 341(1–2):147–155

    Article  PubMed  CAS  Google Scholar 

  7. Ikeda A, Takemura A, Ono H (2000) Preparation of low-molecular weight alginic acid by acid hydrolysis. Carbohydr Polym 42(4):421–425

    Article  CAS  Google Scholar 

  8. Atkins ED, Nieduszynski IA, Mackie W, et al (1973) Structural components of alginic acid II. The crystalline structure of poly-alpha-L-guluronic acid. Results of x-ray diffraction and polarized infrared studies. Biopolymers 12(8):1879–1887

    Article  PubMed  CAS  Google Scholar 

  9. Daudon M, Bader CA, Jungers P (1993) Urinary calculi: review of classification methods and correlations with etiology. Scanning Microsc 7(3):1081–1104

    PubMed  CAS  Google Scholar 

  10. Zhao X, Yu GL, Guan HH, et al (2007) Preparation of low-molecular-weight polyguluronate sulfate and its anticoagulant and anti-inflammatory activities. Carbohyd Polym 69(2):272–279

    Article  CAS  Google Scholar 

  11. Strassner C, Friesen A (1995) Therapy of candiduria by alkalinization of urine. Oral treatment with potassium-sodium-hydrogen citrate. Fortschr Med 113(25):359–362

    PubMed  CAS  Google Scholar 

  12. Ashby RA, Sleet RJ (1992) The role of citrate complexes in preventing urolithiasis. Clin Chim Acta 210(3):157–165

    Article  PubMed  CAS  Google Scholar 

  13. Yamaguchi S, Wiessner JH, Hasegawa AT, et al (2005) Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions. Int J Urol 12(3):290–298

    Article  PubMed  CAS  Google Scholar 

  14. Sriboonlue P, Suwantrai S, Prasongwatana V (1998) An indirect method for urinary oxalate estimation. Clin Chim Acta 273(1):59–68

    Article  PubMed  CAS  Google Scholar 

  15. Vargas R, Perez RM, Perez S, et al (1999) Antiurolithiatic activity of Raphanus sativus aqueous extract on rats. J Ethnopharmacol 68(1–3):335–338

    Article  PubMed  CAS  Google Scholar 

  16. Rosiello AP, Essignmann JM, Wogan GN (1977) Rapid and accurate determination of the median lethal dose (LD50) and its error with a small computer. J Toxicol Environ Health 3(5–6):797–809

    Article  PubMed  CAS  Google Scholar 

  17. Halabe A, Shor R, Wong NLM, et al (2003) Effect of vitamin D3 on the conversion of ethylene glycol to glycolate and oxalate in ethylene glycol-fed rats. Clin Chim Acta 330(1–2):135–139

    Article  PubMed  CAS  Google Scholar 

  18. Boeve ER, Ketelaars GA, Vermeij M, et al (1993) An ultrastructural study of experimentally induced microliths in rat proximal and distal tubules. J Urol 149(4):893–899

    PubMed  CAS  Google Scholar 

  19. Satoh M, Munakata K, Kitoh K, et al (1984) A newly designed model for infection-induced bladder stone formation in the rat. J Urol 132(6):1247–1249

    PubMed  CAS  Google Scholar 

  20. Joyamma V, Rao SG, Hrishikeshavan HJ, et al (1990) Biochemical mechanisms and effects of Mimosa pudica (Linn) on experimental urolithiasis in rats. Indian J Exp Biol 28(3):237–240

    PubMed  CAS  Google Scholar 

  21. Cao LC, Boeve ER, Schroder FH, et al (1992) The effect of two new semi-synthetic glycosaminoglycans (G871, G872) on the zeta potential of calcium oxalate crystals and on growth and agglomeration. J Urol 147(6):1643–1646

    PubMed  CAS  Google Scholar 

  22. Boeve ER, Cao LC, Deng G, et al (1996) Effect of two new polysaccharides on growth, agglomeration and zeta potential of calcium phosphate crystals. J Urol 155(1):368–373

    Article  PubMed  CAS  Google Scholar 

  23. Verhulst A, Asselman M, De Naeyer S, et al (2005) Preconditioning of the distal tubular epithelium of the human kidney precedes nephrocalcinosis. Kidney Int 68(4):1643–1647

    Article  PubMed  Google Scholar 

  24. Asselman M, Verhulst A, De Broe ME, et al (2003) Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/ regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol 14(12):3155–3166

    Article  PubMed  CAS  Google Scholar 

  25. Deng G, Geng MY, Cao LC, et al (1999) The alteration of urinary glycosaminoglcyans and urinary inhibitory activity to calcium oxalate monohydrate after PGS oral administration. J Ocean Univ Qingdao 29(4):627–632

    CAS  Google Scholar 

  26. Erturk E, Kiernan M, Schoen SR (2002) Clinical association with urinary glycosaminoglycans and urolithiasis. Urology 59(4):495–499

    Article  PubMed  Google Scholar 

  27. Lilly JD, Parsons CL (1990) Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet 171(6):493–496

    PubMed  CAS  Google Scholar 

  28. Gill WB, Jones KW, Ruggiero KJ (1982) Protective effects of heparin and other sulfated glycosaminoglycans on crystal adhesion to injured urothelium. J Urol 127(1):152–154

    PubMed  CAS  Google Scholar 

  29. Anderson VR, Perry CM (2006) Pentosan polysulfate: a review of its use in the relief of bladder pain or discomfort in interstitial cystitis. Drugs 66(6):821–835

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by the National Key Technology R&D Program of China (2002AA2Z3145). We are grateful to Dr. Wengang Chai (Imperial College London and Ocean Univeristy of China, supported by OUC Luka program 1405-814147) for helpful discussion in manuscript preparation.

Author information

Authors and Affiliations

  1. Institute of Marine Drug and Food, Ocean University of China, Qingdao, 266003, People’s Republic of China

    Xia Zhao, Guangli Yu & Huashi Guan

  2. Tianjin Institute of Pharmaceutical Research, Tianjin, 300193, People’s Republic of China

    Nan Yue

Authors
  1. Xia Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guangli Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nan Yue
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Huashi Guan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xia Zhao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, X., Yu, G., Yue, N. et al. Effects of low-molecular-weight polyguluronate sulfate on experimental urolithiasis in rats. Urol Res 35, 301–306 (2007). https://doi.org/10.1007/s00240-007-0113-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-007-0113-5

Keywords

Search

Navigation